FireGate Biotech — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Total funding raised: $3.2M

Overview

FireGate Biotech is a private, preclinical-stage biotech founded in 2018, targeting complex diseases in oncology, immunology, and virology with a multi-target immunotherapy platform. The company appears to be in an early research and development phase, with a pipeline yet to be publicly detailed, positioning it as a high-potential, high-risk venture. Its success will hinge on validating its scientific platform, advancing candidates into clinical trials, and securing substantial partnership or investment capital to fund its ambitious research programs across multiple therapeutic areas.

OncologyImmunologyVirologyNeuro-immunology

Technology Platform

Multi-target immunotherapy platform guided by a mechanism-led development strategy.

Funding History

1

Total raised:$3.2M

Seed$3.2MUndisclosedMar 15, 2023

Opportunities

The company is targeting massive and growing markets in oncology, immunology, and virology with a modern multi-target immunotherapy approach.

A validated platform could generate multiple high-value drug candidates and attract significant partnership or acquisition interest from large pharmaceutical companies.

Risk Factors

The company faces high scientific risk as its undisclosed platform may fail to produce effective or safe candidates.

As a private, pre-revenue, preclinical-stage biotech, it is heavily dependent on external financing in a challenging capital environment and operates in intensely competitive therapeutic landscapes.

Competitive Landscape

FireGate Biotech competes in crowded fields dominated by large pharma and well-funded biotechs. In oncology and immunology, competitors range from developers of checkpoint inhibitors and cytokine therapies to advanced cell and gene therapies. Differentiation will require demonstrating superior efficacy or safety through its multi-target approach.

More companies in Immunotherapy / Immuno-Oncology →More companies in United States →